These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 36374511)

  • 1. Physical Activity and Rising Neurofilament Light Chain in Genetic Frontotemporal Degeneration-Diagnosis Is Not Destiny.
    Massimo L; Cousins KAQ
    JAMA Neurol; 2023 Jan; 80(1):14-16. PubMed ID: 36374511
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum neurofilament light chain in genetic frontotemporal dementia: a longitudinal, multicentre cohort study.
    van der Ende EL; Meeter LH; Poos JM; Panman JL; Jiskoot LC; Dopper EGP; Papma JM; de Jong FJ; Verberk IMW; Teunissen C; Rizopoulos D; Heller C; Convery RS; Moore KM; Bocchetta M; Neason M; Cash DM; Borroni B; Galimberti D; Sanchez-Valle R; Laforce R; Moreno F; Synofzik M; Graff C; Masellis M; Carmela Tartaglia M; Rowe JB; Vandenberghe R; Finger E; Tagliavini F; de Mendonça A; Santana I; Butler C; Ducharme S; Gerhard A; Danek A; Levin J; Otto M; Frisoni GB; Cappa S; Pijnenburg YAL; Rohrer JD; van Swieten JC;
    Lancet Neurol; 2019 Dec; 18(12):1103-1111. PubMed ID: 31701893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of neurofilament light chain in frontotemporal dementia: a meta-analysis.
    Karantali E; Kazis D; Chatzikonstantinou S; Petridis F; Mavroudis I
    Aging Clin Exp Res; 2021 Apr; 33(4):869-881. PubMed ID: 32306372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum neurofilament light chain as a preclinical marker of neurodegeneration.
    Parnetti L; Gaetani L; Di Filippo M
    Lancet Neurol; 2019 Dec; 18(12):1070-1071. PubMed ID: 31701888
    [No Abstract]   [Full Text] [Related]  

  • 5. Plasma neurofilament light chain protein is not increased in treatment-resistant schizophrenia and first-degree relatives.
    Eratne D; Janelidze S; Malpas CB; Loi S; Walterfang M; Merritt A; Diouf I; Blennow K; Zetterberg H; Cilia B; Wannan C; Bousman C; Everall I; Zalesky A; Jayaram M; Thomas N; Berkovic SF; Hansson O; Velakoulis D; Pantelis C; Santillo A;
    Aust N Z J Psychiatry; 2022 Oct; 56(10):1295-1305. PubMed ID: 35179048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurofilament marks prodrome onset in FTD.
    Wood H
    Nat Rev Neurol; 2023 Sep; 19(9):508. PubMed ID: 37553391
    [No Abstract]   [Full Text] [Related]  

  • 7. Serum Neurofilament Light in Patients with Frontotemporal Dementia Caused by CHMP2B Mutation.
    Toft A; Roos P; Jääskeläinen O; Musaeus CS; Henriksen EE; Johannsen P; Nielsen TT; Herukka SK; Hviid Simonsen A; Nielsen JE
    Dement Geriatr Cogn Disord; 2020; 49(6):533-538. PubMed ID: 33626531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A pilot study of the utility of cerebrospinal fluid neurofilament light chain in differentiating neurodegenerative from psychiatric disorders: A 'C-reactive protein' for psychiatrists and neurologists?
    Eratne D; Loi SM; Walia N; Farrand S; Li QX; Varghese S; Walterfang M; Evans A; Mocellin R; Dhiman K; Gupta V; Malpas CB; Collins S; Masters CL; Velakoulis D
    Aust N Z J Psychiatry; 2020 Jan; 54(1):57-67. PubMed ID: 31220922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Cerebrospinal Fluid Neurofilament Light Protein Levels With Cognition in Patients With Dementia, Motor Neuron Disease, and Movement Disorders.
    Olsson B; Portelius E; Cullen NC; Sandelius Å; Zetterberg H; Andreasson U; Höglund K; Irwin DJ; Grossman M; Weintraub D; Chen-Plotkin A; Wolk D; McCluskey L; Elman L; Shaw LM; Toledo JB; McBride J; Hernandez-Con P; Lee VM; Trojanowski JQ; Blennow K
    JAMA Neurol; 2019 Mar; 76(3):318-325. PubMed ID: 30508027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluid Biomarkers of Frontotemporal Lobar Degeneration.
    van der Ende EL; van Swieten JC
    Adv Exp Med Biol; 2021; 1281():123-139. PubMed ID: 33433873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma Neurofilament Light Chain and Clinical Diagnosis in Frontotemporal Dementia Syndromes.
    Ooi S; Patel SK; Eratne D; Kyndt C; Reidy N; Lewis C; Lee SCM; Darby D; Brodtmann A
    J Alzheimers Dis; 2022; 89(4):1221-1231. PubMed ID: 35988220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurofilament light chain protein in neurodegenerative dementia: A systematic review and network meta-analysis.
    Zhao Y; Xin Y; Meng S; He Z; Hu W
    Neurosci Biobehav Rev; 2019 Jul; 102():123-138. PubMed ID: 31026486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances and controversies in frontotemporal dementia: diagnosis, biomarkers, and therapeutic considerations.
    Boeve BF; Boxer AL; Kumfor F; Pijnenburg Y; Rohrer JD
    Lancet Neurol; 2022 Mar; 21(3):258-272. PubMed ID: 35182511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Combination of Neurofilament Light, Glial Fibrillary Acidic Protein, and Neuronal Pentraxin-2 Discriminates Between Frontotemporal Dementia and Other Dementias.
    Bolsewig K; Hok-A-Hin YS; Sepe FN; Boonkamp L; Jacobs D; Bellomo G; Paoletti FP; Vanmechelen E; Teunissen CE; Parnetti L; Willemse EAJ
    J Alzheimers Dis; 2022; 90(1):363-380. PubMed ID: 36120776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurofilament Light Chain Levels in Frontotemporal Dementia and Progressive Supranuclear Palsy: A Systematic Review.
    Bendstrup N; Hejl AM; Salvesen L
    J Alzheimers Dis; 2022; 87(1):131-140. PubMed ID: 35275542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurofilament Light Chain as a Biomarker in Cerebral Small-Vessel Disease.
    Peters N
    Mol Diagn Ther; 2022 Jan; 26(1):1-6. PubMed ID: 34825310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of CSF and serum neurofilament light and heavy chain as differential diagnostic biomarkers for ALS.
    Halbgebauer S; Steinacker P; Verde F; Weishaupt J; Oeckl P; von Arnim C; Dorst J; Feneberg E; Mayer B; Rosenbohm A; Silani V; Ludolph AC; Otto M
    J Neurol Neurosurg Psychiatry; 2022 Jan; 93(1):68-74. PubMed ID: 34417339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum neurofilament light chain as a surrogate of cognitive decline in sporadic and familial frontotemporal dementia.
    Silva-Spínola A; Lima M; Leitão MJ; Durães J; Tábuas-Pereira M; Almeida MR; Santana I; Baldeiras I
    Eur J Neurol; 2022 Jan; 29(1):36-46. PubMed ID: 34375485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurofilament assessment in patients with cervical dystonia.
    Ferrazzano G; Zingaropoli MA; Costanzo M; Belvisi D; Dominelli F; Pasculli P; Ciardi MR; Fabbrini G; Defazio G; Berardelli A; Conte A
    Parkinsonism Relat Disord; 2022 May; 98():70-71. PubMed ID: 35487128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum neurofilament light chain in behavioral variant frontotemporal dementia.
    Steinacker P; Anderl-Straub S; Diehl-Schmid J; Semler E; Uttner I; von Arnim CAF; Barthel H; Danek A; Fassbender K; Fliessbach K; Foerstl H; Grimmer T; Huppertz HJ; Jahn H; Kassubek J; Kornhuber J; Landwehrmeyer B; Lauer M; Maler JM; Mayer B; Oeckl P; Prudlo J; Schneider A; Volk AE; Wiltfang J; Schroeter ML; Ludolph AC; Otto M;
    Neurology; 2018 Oct; 91(15):e1390-e1401. PubMed ID: 30209235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.